Free Trial

Rep. Tim Moore Sells Colgate-Palmolive Company (NYSE:CL) Stock

Colgate-Palmolive logo with Consumer Staples background

Key Points

  • Representative Tim Moore sold shares of Colgate-Palmolive Company for between $1,001 and $15,000 on September 10th, as disclosed in a filing on October 10th.
  • Colgate-Palmolive's stock recently increased by 1.9%, trading at $78.43 with a market capitalization of $63.39 billion.
  • The company announced a quarterly dividend of $0.52 per share, with an annualized yield of 2.7%, payable on November 14th.
  • MarketBeat previews the top five stocks to own by November 1st.

Representative Tim Moore (R-North Carolina) recently sold shares of Colgate-Palmolive Company NYSE: CL. In a filing disclosed on October 10th, the Representative disclosed that they had sold between $1,001 and $15,000 in Colgate-Palmolive stock on September 10th. The trade occurred in the Representative's "TRADEWINDS" account.

Representative Tim Moore also recently made the following trade(s):

  • Sold $50,001 - $100,000 in shares of Hyster-Yale NYSE: HY on 9/19/2025.
  • Purchased $50,001 - $100,000 in shares of Hyster-Yale NYSE: HY on 9/11/2025.
  • Purchased $15,001 - $50,000 in shares of Coinbase Global NASDAQ: COIN on 9/11/2025.
  • Sold $1,001 - $15,000 in shares of Procter & Gamble NYSE: PG on 9/10/2025.
  • Sold $100,001 - $250,000 in shares of Centene NYSE: CNC on 8/18/2025.
  • Sold $50,001 - $100,000 in shares of UnitedHealth Group NYSE: UNH on 8/15/2025.
  • Sold $100,001 - $250,000 in shares of Intel NASDAQ: INTC on 8/13/2025.
  • Sold $50,001 - $100,000 in shares of Hyster-Yale NYSE: HY on 8/13/2025.
  • Purchased $15,001 - $50,000 in shares of Hyster-Yale NYSE: HY on 8/12/2025.
  • Purchased $15,001 - $50,000 in shares of Intel NASDAQ: INTC on 8/11/2025.

Colgate-Palmolive Stock Up 1.9%

CL stock traded up $1.45 during midday trading on Tuesday, hitting $78.43. The company's stock had a trading volume of 5,514,821 shares, compared to its average volume of 5,299,127. Colgate-Palmolive Company has a twelve month low of $76.68 and a twelve month high of $102.61. The stock has a market capitalization of $63.39 billion, a P/E ratio of 22.03, a PEG ratio of 4.29 and a beta of 0.34. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. The company's fifty day moving average price is $82.44 and its 200 day moving average price is $87.73.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, topping analysts' consensus estimates of $0.89 by $0.03. The business had revenue of $5.11 billion for the quarter, compared to the consensus estimate of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm's revenue for the quarter was up 1.0% on a year-over-year basis. During the same period in the previous year, the company earned $0.91 earnings per share. As a group, equities research analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be given a $0.52 dividend. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a yield of 2.7%. Colgate-Palmolive's dividend payout ratio (DPR) is 58.43%.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on CL. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Colgate-Palmolive in a report on Wednesday, October 8th. Barclays dropped their price objective on Colgate-Palmolive from $87.00 to $82.00 and set an "equal weight" rating on the stock in a research note on Wednesday, October 1st. UBS Group reduced their target price on Colgate-Palmolive from $99.00 to $92.00 and set a "buy" rating for the company in a research note on Wednesday, October 8th. Citigroup decreased their target price on Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating on the stock in a report on Monday, August 4th. Finally, Piper Sandler initiated coverage on Colgate-Palmolive in a report on Friday, October 3rd. They set a "neutral" rating and a $84.00 price target for the company. Eight research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $92.21.

Check Out Our Latest Stock Analysis on Colgate-Palmolive

Institutional Trading of Colgate-Palmolive

Several hedge funds and other institutional investors have recently bought and sold shares of CL. Personal CFO Solutions LLC acquired a new stake in shares of Colgate-Palmolive in the first quarter valued at approximately $285,000. Vision Capital Management Inc. bought a new position in Colgate-Palmolive during the 1st quarter worth $322,000. Autumn Glory Partners LLC raised its holdings in Colgate-Palmolive by 67.4% in the 1st quarter. Autumn Glory Partners LLC now owns 8,905 shares of the company's stock valued at $851,000 after acquiring an additional 3,586 shares in the last quarter. Financial Gravity Asset Management Inc. bought a new stake in shares of Colgate-Palmolive during the 1st quarter valued at $2,166,000. Finally, Penserra Capital Management LLC grew its holdings in shares of Colgate-Palmolive by 398.6% during the 1st quarter. Penserra Capital Management LLC now owns 10,651 shares of the company's stock worth $997,000 after purchasing an additional 8,515 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.

About Representative Moore

Timothy K. Moore (Republican Party) is a member of the U.S. House, representing North Carolina's 14th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Moore (Republican Party) ran for election to the U.S. House to represent North Carolina's 14th Congressional District. He won in the general election on November 5, 2024. Moore served as speaker of the House from 2015 to 2025. Timothy Moore earned his B.A. from the University of North Carolina-Chapel Hill in 1992 and his J.D. from the Oklahoma City University School of Law in 1995. His professional experience includes working as an attorney.

About Colgate-Palmolive

(Get Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Colgate-Palmolive Right Now?

Before you consider Colgate-Palmolive, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.

While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.